Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer
NCT01396681
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Cancer
Interventions
DRUG:
gemcitabine and cisplatin
Sponsor
Seoul National University Hospital